Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more
SeekingAlpha
SeekingAlpha
SeekingAlpha
MarketWatch
Access detailed stock analysis from LSEG including analyst price target estimates.